SCHEMBL3629100

SCHEMBL3629100

CCC(=Cc1ccc(N)cc1C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TBXAS1 P24557 2/20 0.35
CASP1 P29466 2/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NQO2 P16083 1/20 0.34
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAOA P21397 1/20 0.33
RAD52 P43351 1/20 0.33
HPGD P15428 2/20 0.33
SHMT2 P34897 1/20 0.33
PRKCI P41743 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629097 1.00 PDE10A (0.38) PDE10AALDH1A1CYP1A2MAPTCYP2C9
SCHEMBL1508506 0.84 MEN1 (0.45) MAPTTBXAS1L3MBTL1LMNAKDM4E
SCHEMBL1508505 0.84 MEN1 (0.45) MAPTTBXAS1L3MBTL1LMNAKDM4E
SCHEMBL1100704 0.83 TBXAS1 (0.34) ALDH1A1MAPTCYP2C9CYP2C19TBXAS1
SCHEMBL1100701 0.83 TBXAS1 (0.34) ALDH1A1MAPTCYP2C9CYP2C19TBXAS1
SCHEMBL5861807 0.80 TBXAS1 (0.39) CYP2C9TBXAS1CYP3A4ESR1MEN1
SCHEMBL5860653 0.79 TBXAS1 (0.39) MAPTCYP2C9TBXAS1CYP3A4ESR1
SCHEMBL24587500 0.77 ALDH1A1 (0.44) ALDH1A1MAPTCYP2C9TBXAS1TSHR
SCHEMBL7947844 0.77 ALDH1A1 (0.44) ALDH1A1MAPTCYP2C9TBXAS1TSHR
SCHEMBL2272484 0.76 GABRP (0.47) ALDH1A1TBXAS1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269220-A1 Aminophenylpropanoic Acid Derivative GPR119, GPR55, GPR65 PDE10A 743/4885ALDH1A1 495/4885CYP1A2 1304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.